This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A study out of China found most patients biopsied for prostate lesions did not have clinically significant cancer, calling the clinical ranking systems into question.
Many women with early-stage HR+HER2- breast cancer and a negative presurgical axillary ultrasound can skip sentinel lymph node biopsy, a study presented April 11 at the American Society of Breast Surgeons Annual Meeting in Orlando, FL, found. In his talk, Andreas Giannakou, MD, from Brigham & Women’s Hospital and Harvard Medical School in Boston showed results suggesting that nodal disease burden and oncologic outcomes among women in a real-world setting are similar to criteria in the Sentin
Occupational doses to radiologic technologists imparted by assistance with fluoroscopically-guided interventional procedures are generally low, but they do need careful monitoring , a team of National Institute of Health (NIH) researchers has found. Investigators led by Cato Milder, PhD, of Rockville, MD-based NCI reported that median annual dose corresponding to performing fluoroscopically-guided interventional procedures was 0.65 mSv, with higher doses associated with close proximity to patien
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Monica Lynch is suing MidState Medical Center in Connecticut Superior Court, claiming the fall resulted in a lack of stroke interventions and further injuries.
Many young women who have breast cancer symptoms delay timely screening and care, according to research presented April 11 at the American Society of Breast Surgeons Annual Meeting in Orlando, FL. In her talk, Katherine Fleshner, MD, from the University of Calgary found that the leading reasons for delaying care include lack of concern, reassurance from another practitioner, difficulty accessing care, and competing priorities.
Many young women who have breast cancer symptoms delay timely screening and care, according to research presented April 11 at the American Society of Breast Surgeons Annual Meeting in Orlando, FL. In her talk, Katherine Fleshner, MD, from the University of Calgary found that the leading reasons for delaying care include lack of concern, reassurance from another practitioner, difficulty accessing care, and competing priorities.
milla1cf Fri, 04/12/2024 - 21:00 April 12, 2024 — GE HealthCare , a leader in breast health technology and diagnostics, will feature its latest breast cancer detection technology during the 2024 Society of Breast Imaging Symposium in Montreal, Canada, April 11-14, 2024. This year’s showcase will feature the Mobile Mammography Screening Truck, the recently released MyBreastAI Suite * and Pristina Bright** offering to demonstrate the company’s personalized approach to transforming breast cancer i
A vision transformer (ViT) AI model outperformed convolutional neural networks when classifying tumors on PET/CT images as benign or malignant, according to a study published April 9 in Scientific Reports. In a head-to-head comparison, researchers at Osaka University in Osaka, Japan, demonstrated that a ViT model performed better than convolutional neural network (CNN) models when classifying findings on PET/CT imaging.
milla1cf Fri, 04/12/2024 - 21:04 April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution for contrast-enhanced mammography (CEM). The two companies will showcase the solution at the annual Society of Breast Imaging Symposium from April 11-14, 2024 in Montreal, Canada. Contrast-enhanced mammography is a sensitive and relatively low-cost breast imaging modality that can be used to support breast cancer diagnosis and help to guide treat
With federal and state-level legislation mandating insurance coverage for supplemental breast imaging and providers disclosing breast density information to patients, it seems like ultrasound would have an immediate and important role in this area. Right? Maybe, but expectations need to be managed, according to Kibo Nam, PhD, from Thomas Jefferson University in Philadelphia, PA.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Canadian AI software developer 16 Bit has received de novo approval from the U.S. Food and Drug Administration (FDA) for Rho, an AI tool for evaluating low bone mineral density (BMD). Rho uses patented AI technology to automatically scan standard x-rays (frontal projections of the chest, thoracic spine, lumbar spine, pelvis, knee, and hand/wrist) for markers of low BMD, an indicator of osteoporosis, 16 Bit said.
Radiologists have again jumped up a spot in earnings among the top 10 specialists in the U.S., according to a Medscape survey. The average income for radiologists was $498,000, up 3% from last year’s average of $483,000, according to Medscape's 2024 Physician Compensation Report , released April 12. This places radiology up one spot over last year to sixth on the list of the top 10 earning specialties.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Discussing findings from a new study presented at the Society for Breast Imaging (SBI) conference, Shahrzad Tavana, M.D., detailed the significant impact of training sessions for MRI technologists in improving breast positioning, optimal field of view and accuracy of sequence submissions to PACS for breast MRI exams.
Bayer and Hologic have entered a collaboration agreement to deliver a coordinated approach for contrast-enhanced mammography (CEM). The offering brings together Bayer’s contrast-enhanced mammography contrast delivery system, called the Medrad Stellant Flex CT injection system, and Hologic’s mammography scanners. The move streamlines the purchasing process for radiologists and imaging facilities and provides setup and ongoing support, Bayer said.
milla1cf Fri, 04/12/2024 - 20:58 April 12, 2024 — RTsafe , a leading provider of quality assurance products and services in stereotactic radiosurgery, and ZAP Surgical , the developer of the ZAP-X Gyroscopic Radiosurgery platform, have announced a partnership to promote advances in cranial radiosurgery. Under the terms of the agreement, RTsafe's dosimetry phantom based on true-to-life human anatomy will be seamlessly integrated into ZAP Surgical's existing and future global installations.
RadNet has tapped basketball legend and WNBA superstar Sheryl Swoopes as spokesperson for its nationwide breast cancer screening programs. Swoopes will emphasize the need for more convenient nationwide access to crucial cancer screening services, with a focus on RadNet’s MammogramNow initiative, which recently launched breast cancer screening services in Walmart Supercenters in Delaware, Arizona, and California, the company said.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Today, we are excited to share updates to our leadership team that will help lead us into our next chapter of innovation and growth. Our founder, Drew Gaudet will step into the Chief Growth Officer role where he will focus on sales, marketing, and growing Premier’s relationships with our clients. In this role Drew will also continue to build our network of top tier radiologists and identify new opportunities to deliver value to our clients.
In this webinar clip, Rajesh Rangaswamy, MD, Medical Director, NeuroInterventional Service, Reno Radiological Associates/Renown Health, dives into the challenges intrinsic to stroke care workflows and how Aidoc’s AI plays a role in impacting patient outcomes. Click here to watch the full webinar. The post The Challenge in Stroke Care and Aidoc's Role appeared first on Healthcare AI | Aidoc Always-on AI.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content